Neurolievebiosciences
1 known investors
Neurolieve Biosciences is developing NLV-01, a first-in-class non-opioid biologic designed to relieve neuropathic pain and promote nerve regeneration while avoiding CNS side effects and addiction risk. The company targets chronic neuropathic pain treatment through biological engineering and is in the preclinical stage.
BiotechDeep TechHealthtech